Brief: Bicycle Therapeutics Reports Third Quarter 2022 Financial Results
03/11/2022 12:53
Nov 3 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS PLC - CASH AND CASH EQUIVALENTS OF
$361.5
MILLION AS OF SEPTEMBER 30, 2022; EXPECTED FINANCIAL RUNWAY INTO
2025
* BICYCLE THERAPEUTICS PLC QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $0.96
Source text for Eikon: ID:nBw84LVa
Further company coverage: BCYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics Q1 revenue drops after partnership terminations
Brief: Bicycle Therapeutics Announces Oral And Poster Presentations At The Aacr Annual Meeting 2026
UK's Bicycle Therapeutics Q4 revenue jumps, proposes 30% workforce reduction
Brief: Bicycle Therapeutics Says Travis Thompson Appointed As CFO, Succeeds Alethia Young
Bicycle Therapeutics Q3 net loss widens as R&D costs rise